[1] |
Tiejun Z, Xiaoming Z, Jilun Z, et al. Fluoroquinolone resistance among Neisseria gonorrhoeae isolates from Shanghai, China: detection of quinolone resistance⁃determining region mutations[J]. Indian J Med Res, 2009, 129(6): 701⁃706.
|
[2] |
Dan M. The use of fluoroquinolones in gonorrhoea: the increasing problem of resistance[J]. Expert Opin Pharmacother, 2004, 5(4): 829⁃854. DOI: 10.1517/14656566.5.4.829.
|
[3] |
Wright DJ, Azadian B. Cephalosporin resistance in gonorrhoea[J]. Lancet Infect Dis, 2013, 13(9): 728⁃730. DOI: 10.1016/S1473⁃3099(13)70161⁃0.
|
[4] |
Cousin S Jr, Whittington WL, Roberts MC. Acquired macrolide resistance genes in pathogenic Neisseria spp. isolated between 1940 and 1987[J]. Antimicrob Agents Chemother, 2003, 47(12): 3877⁃3880. DOI: 10.1128/AAC.47.12.3877⁃3880.2003.
|
[5] |
Olesky M, Hobbs M, Nicholas RA. Identification and analysis of amino acid mutations in porin IB that mediate intermediate⁃level resistance to penicillin and tetracycline in Neisseria gonorrhoeae[J]. Antimicrob Agents Chemother, 2002, 46(9): 2811⁃2820. DOI: 10.1128/AAC.46.9.2811⁃2820.2002.
|
[6] |
World Health Organization. Sensitivity testing of Neisseria gonorrhoeae: methodologies for use by participants in the WHO Western Pacific Regional Resistance Surveillance Programme[S]. In: WHO/WPR Regional Antimicrobial Surveillance Working Group Meeting Proceedings, 1992: 33⁃34.
|
[7] |
Hooper DC. Emerging mechanisms of fluoroquinolone resistance[J]. Emerging Infect Dis, 2001, 7(2): 337⁃341. DOI: 10.3201/eid0702.700337.
|
[8] |
Vereshchagin VA, Ilina EN, Malakhova MV, et al. Fluoro⁃quinolone⁃resistant Neisseria gonorrhoeae isolates from Russia: molecular mechanisms implicated[J]. J Antimicrob Chemother, 2004, 53(4): 653⁃656. DOI: 10.1093/jac/dkh145 .
|
[9] |
Shafer WM, Veal WL, Lee EH, et al. Genetic organization and regulation of antimicrobial efflux systems possessed by Neisseria gonorrhoeae and Neisseria meningitidis[J]. J Mol Microbiol Biotechnol, 2001, 3(2): 219⁃224.
|
[10] |
Belland RJ, Morrison SG, Ison C, et al. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone⁃resistant isolates[J]. Mol Microbiol, 1994, 14(2): 371⁃380.
|
[11] |
Lindbäck E, Rahman M, Jalal S, et al. Mutations in gyrA, gyrB, parC, and parE in quinolone⁃resistant strains of Neisseria gonorrhoeae[J]. APMIS, 2002, 110(9): 651⁃657.
|
[12] |
Su X, Lind I. Molecular basis of high⁃level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998[J]. Antimicrob Agents Chemother, 2001, 45(1): 117⁃123. DOI: 10.1128/AAC.45.1.117⁃123.2001
|
[13] |
Starnino S, Dal Conte I, Matteelli A, et al. Trend of ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Italy and analysis of the molecular determinants[J]. Diagn Microbiol Infect Dis, 2010, 67(4): 350⁃354. DOI: 10.1016/j.diagmicrobio.2010.03.001.
|
[14] |
Yang Y, Liao M, Gu WM, et al. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai[J]. J Antimicrob Chemother, 2006, 58(4): 868⁃872. DOI: 10.1093/jac/dkl301.
|
[15] |
Buono S, Wu A, Hess DC, et al. Using the Neisseria gonorrhoeae multiantigen sequence⁃typing method to assess strain diversity and antibiotic resistance in San Francisco, California[J]. Microb Drug Resist, 2012, 18(5): 510⁃517. DOI: 10.1089/mdr.2011.0229.
|
[16] |
Florindo C, Pereira R, Boura M, et al. Genotypes and anti⁃microbial⁃resistant phenotypes of Neisseria gonorrhoeae in Portugal (2004⁃2009)[J]. Sex Transm Infect, 2010, 86(6): 449⁃453. DOI: 10.1136/sti.2010.044321.
|
[17] |
De Jongh M, Dangor Y, Ison CA, et al. Neisseria gonorrhoeae multi⁃antigen sequence typing (NG⁃MAST) of ciprofloxacin resistant isolates of Pretoria, South Africa[J]. J Clin Pathol, 2008, 61(5): 686⁃687. DOI: 10.1136/jcp.2007.052191.
|